Cabozantinib plus atezolizumab showed promising antitumour activity in patients with metastatic castration-resistant prostate cancer after novel hormonal therapy with an acceptable safety profile, supporting further evaluation of this combination.
COSMIC-021 trial: Cabozantinib plus... - Advanced Prostate...
COSMIC-021 trial
Written by
spw1
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Radiotherapy clinical trial opinions
Hi everyone.
After having my prostate removed on the 29th March 16, my urologist referred me to an...
Antigen vaccine trial is promising.
com/2019/02/25/prostate-cancer-study-at-wash-u-school-of-medicine-shows-promise-in-leading-to-a-cure
Continue on Eclipse Trial or not?
Zytiga clinical trial
Keytruda /Xtandi trial 
Vision trial completion
Lu-177 \"Vision\" Trial Results..
